Achieve Life Sciences, Inc. Share Price

Achieve Life Sciences, Inc. Share Price

NASDAQ: ACHV
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Achieve Life Sciences, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Achieve Life Sciences, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Achieve Life Sciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.08
Revenue (TTM)
$0.00
Return On Equity (TTM)
-61.81%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
17.39%

Achieve Life Sciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.66-$10.17-$74.77-$12.11
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A30.63%-635.20%83.80%

Achieve Life Sciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$42.35-$29.82-$39.83-$54.65
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A29.59%-33.57%-37.21%

About Achieve Life Sciences, Inc.

Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.

Achieve Life Sciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

ACHV Share Price FAQs